Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analyst predicts the global hospital-acquired urinary tract infection testing market to grow at a CAGR of around 19% between 2016 and 2020. Urinary tract infection occupies the largest share in the HAIs category, and the number is constantly growing. This has encouraged several vendors to develop innovative testing products that will subsequently augment the demand for hospital-acquired urinary tract infection testing products. Several technological advancements have enhanced the testing procedures for urinary tract infection, as they are more precise, sensitive, generate faster outcomes, and provide a broader range of pathogen detection as compared with the most traditional methods. Moreover, the innovative techniques in bioinformatics and software programs help manage a massive amount of data and offer better-quality results from tests such as molecular diagnostics. These methods provide initiation of infection control practices, optimization of treatment selection, reduced hospital stay, and improved surveillance of infectious diseases. Also, hospitals are setting up infection control committees that focus on only HAIs. Such infection control committee is responsible for the evaluation and planning of evidence-based practice, resource allocation, and prioritization of matters related to infection control.
Geographically, the Americas dominated the market and accounted for the largest market share in 2015. The high prevalence of infectious diseases, leading to the increased demand for diagnostic products and services and focus on disease management has propelled market growth in this region. The US is the largest revenue contributor for the hospital-acquired UTI testing market in the Americas owing to the massive sales of infectious disease diagnostic products and urology devices. Moreover, factors like increased laboratory automation, the shift toward rapid POC diagnostic tests, and approval of new products by the Food and Drug Administration (FDA) will further boost the market’s growth in the coming years.
The global hospital-acquired UTI testing device market is highly fragmented with the presence of large, medium, and small-sized companies. The key vendors in the market are forming partnerships and offering premium-priced products to sustain their market shares. However, the local vendors are selling products at lower prices, which is posing a serious threat to the large companies. The increasing prevalence of infectious diseases gives significant opportunities to the life science companies to focus on their R&D investments on devices for the efficient diagnosis of infectious diseases. Companies such as Siemens Healthineers, bioMerieux, Roche Diagnostics, and Beckman Coulter have expanded their product portfolio for diagnosis of most communicable diseases. Moreover, constant advances in technology, and innovative product launches will further increase the competition among vendors.
Leading vendors in the market are -
Other prominent vendors in the hospital-acquired UTI testing market include ACON Laboratories, Alere, ARKRAY, Beckman Coulter, Becton Dickinson and Company (BD), Bio-Rad, Cepheid, Labomed, Mindray, Sysmex, Thermo Fisher Scientific, and URIT Medical.
The assay kits and consumables segment accounts for the largest market share and generates a high return on investments for manufacturers, as they are used in greater quantities for sample analysis. Some assay kits are highly precise to certain pathogens. Consumables are used in bulk during sample analysis and multiple times. Multistix 10 SG reagent strips from Siemens Healthineers is one of the widely-used reagents strips to detect the UTIs in the market.
Hospitals occupy a larger share of the hospital-acquired UTI testing market, as the surgery for urinary incontinence, urinary retention, and prostate or genitals procedures are more common in hospitals. Most of the UTIs happen especially in the ICUs due to the increased usage of urinary catheters. The increase in HAIs in individuals annually prompts the hospital authorities to make more investments in this sector. With the increasing number of hospitals worldwide, the revenue in the UTI test market will also increase substantially. Moreover, several hospitals are also opting for advanced technological UTI testing systems to maintain high revenues in the overall UTI testing market.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by technology
PART 07: Market segmentation by product
PART 08: Market segmentation by end-user
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
PART 18: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.